Moderna's sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021.
Pro There is a solution to ending the pandemic! Fund Vaxart’s COVID19 💊 vaccine that is currently in phase 2 trials that can be made cheaper, faster, is room temperature stable, and can be self administered. It also has better T-cell response & targets mucosal immunity.
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
European markets set for modest rise, with earnings in focus; HSBC beatsEuropean stocks are set to open slightly higher on Monday as investors continue to monitor corporate earnings, Covid-19 and the inflation picture. good
Consulte Mais informação »
Goldman Sachs has upgraded a raft of stocks to 'buy.' Here are 10 of its picksNew for subscribers: Goldman Sachs has upgraded a raft of stocks to 'buy.' Here are 10 of its picks. Check out CNBCPro today.
Consulte Mais informação »